Ear Care in the US

Date: April 26, 2013
Pages: 34
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

The sale of Debrox to Prestige Brands marked GlaxoSmithKline’s departure from ear care in the US. Given that GlaxoSmithKline formerly led sales, the move represented a strategic shake-up in a category that witnessed very little development over the review period. The acquisition gives Prestige a majority share of ear care, placing it in a strong competitive position against both private label and smaller branded competitors.

Euromonitor International's Ear Care in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Ear Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Competitive Landscape
Category Data
  Table 1 Sales of Ear Care: Value 2007-2012
  Table 2 Sales of Ear Care: % Value Growth 2007-2012
  Table 3 Ear Care Company Shares by Value 2008-2012
  Table 4 Ear Care Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Ear Care: Value 2012-2017
  Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 CVS Caremark Corp: Key Facts
Summary 2 CVS Caremark Corp: Operational Indicators (Retail Pharmacy Segment)
Company Background
Competitive Positioning
Summary 3 CVS Caremark Corp: Competitive Position 2012
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 4 Walgreen Co: Key Facts
Summary 5 Walgreen Co: Operational Indicators
Company Background
Competitive Positioning
Summary 6 Walgreen Co: Competitive Position 2012
Executive Summary
Consumer Health Continues Its Upward Climb
Manufacturing Issues Worsen Rather Than Improve
Private Label Producers Capitalise on Branded Product Challenges
Retailers Aim To Play A Broader Role in Consumers' Lives
OTC Rebound Will Drive Higher Growth Over the Forecast Period
Key Trends and Developments
Continuing the Balance Between Industry and Government
Baby Boomers Impact on Vitamins and Dietary Supplements
Growth in Protein Is Bulking Up in Strength
Manufacturing Issues Continue To Plague Consumer Health
Regulatory Prospects Alter Strategic Landscape
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Penetration of Private Label by Category 2007-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 7 OTC: Switches 2010-2012
Summary 8 Research Sources
Skip to top

Ear Care - Singapore US$ 990.00 Mar, 2010 · 32 pages
Ear Care in Spain US$ 990.00 Jul, 2013 · 27 pages
Ear Care in Tunisia US$ 990.00 May, 2013 · 18 pages

Ask Your Question

Ear Care in the US
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: